Ralph mentioned at the roadshow that they are currently in negotiations with 3 venture capital backed companies regarding their organ on chip technology. He said these 3 companies are not start ups with one of them just finishing a Series B round raising of Us$80 mil.
None of this has been factored into any of Ralph's forecasts.
Just another possible big upside.
What would be the value of a company that solely developed organ on a chip and nothing else and was in current talks for commercialisation ?
Ralph mentioned at the roadshow that they are currently in...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
